Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.96
+0.10 (1.71%)
At close: Mar 23, 2026, 4:00 PM EDT
5.72
-0.24 (-4.00%)
After-hours: Mar 23, 2026, 5:16 PM EDT
Champions Oncology Market Cap
Champions Oncology has a market cap or net worth of $82.77 million as of March 23, 2026. Its market cap has decreased by -40.16% in one year.
Market Cap
82.77M
Enterprise Value
82.58M
1-Year Change
-40.16%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since February 2, 2007, Champions Oncology's market cap has increased from $10.70M to $82.77M, an increase of 673.51%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 81.40M | -15.21% |
| Dec 31, 2025 | 96.00M | -18.92% |
| Dec 31, 2024 | 118.40M | 54.97% |
| Dec 29, 2023 | 76.40M | 25.04% |
| Dec 30, 2022 | 61.10M | -45.93% |
| Dec 31, 2021 | 113.00M | -21.69% |
| Dec 31, 2020 | 144.30M | 49.07% |
| Dec 31, 2019 | 96.80M | 8.04% |
| Dec 31, 2018 | 89.60M | 110.33% |
| Dec 29, 2017 | 42.60M | 53.79% |
| Dec 30, 2016 | 27.70M | -10.93% |
| Dec 31, 2015 | 31.10M | -6.89% |
| Dec 31, 2014 | 33.40M | -58.35% |
| Dec 31, 2013 | 80.20M | 468.79% |
| Dec 31, 2012 | 14.10M | -59.94% |
| Dec 30, 2011 | 35.20M | 6.02% |
| Dec 31, 2010 | 33.20M | 26.24% |
| Dec 31, 2009 | 26.30M | -26.74% |
| Dec 31, 2008 | 35.90M | -19.14% |
| Dec 31, 2007 | 44.40M | 314.95% |
| Feb 2, 2007 | 10.70M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 85.82M |
| NeurAxis | 85.25M |
| Vivani Medical | 84.62M |
| Impact BioMedical | 84.10M |
| Kazia Therapeutics | 81.50M |
| Seres Therapeutics | 81.48M |
| Biomea Fusion | 80.60M |
| Spruce Biosciences | 80.13M |